These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 21942305)

  • 21. AHRQ's evidence-based practice centres prove viable. Agency for Healthcare Research and Quality.
    Newman L
    Lancet; 2000 Dec; 356(9246):1990. PubMed ID: 11130533
    [No Abstract]   [Full Text] [Related]  

  • 22. Evidence-based practice: AHRQ's role in generating and disseminating knowledge.
    Coopey M; Nix MP; Clancy CM
    AORN J; 2007 Nov; 86(5):857-60. PubMed ID: 17998005
    [No Abstract]   [Full Text] [Related]  

  • 23. AHRQ healthcare exchange: promoting adoption of innovations.
    Clutter PC
    Crit Care Nurs Q; 2009; 32(1):62-8. PubMed ID: 19077812
    [TBL] [Abstract][Full Text] [Related]  

  • 24. AHRQ's Effective Health Care Program: why comparative effectiveness matters.
    Slutsky JR; Clancy CM
    Am J Med Qual; 2009; 24(1):67-70. PubMed ID: 19139466
    [No Abstract]   [Full Text] [Related]  

  • 25. Prioritizing Evidence-based Interventions for Dissemination and Implementation Investments: AHRQ's Model and Experience.
    Huppert JS; Fournier AK; Bihm JL; Chang CS; Miller TL; Nourjah P; Chang SM; Bierman AS
    Med Care; 2019 Oct; 57 Suppl 10 Suppl 3(10 Suppl 3):S272-S277. PubMed ID: 31517799
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Agency for Healthcare Research and Quality (AHRQ) effective health care (EHC) program methods guide for comparative effectiveness reviews: keeping up-to-date in a rapidly evolving field.
    Chang SM
    J Clin Epidemiol; 2011 Nov; 64(11):1166-7. PubMed ID: 21959053
    [No Abstract]   [Full Text] [Related]  

  • 27. New US centre to boost comparative health research.
    Vogel L
    CMAJ; 2010 Jul; 182(10):E457-8. PubMed ID: 20513786
    [No Abstract]   [Full Text] [Related]  

  • 28. Financial impact of clinical research on a health system.
    Wermeling DP; Piecoro LT; Foster TS
    Am J Health Syst Pharm; 1997 Aug; 54(15):1742-51. PubMed ID: 9262748
    [No Abstract]   [Full Text] [Related]  

  • 29. Introduction: Medicare Section 1013 and AHRQ's Effective Health Care Program.
    Chao SH; Urbano FL
    J Manag Care Pharm; 2007 Jan; 13(1 Suppl):S3-6. PubMed ID: 17378699
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Funding opportunities in knowledge translation: review of the AHRQ's "Translating Research into Practice" initiatives, competing funding agencies, and strategies for success.
    Handrigan M; Slutsky J
    Acad Emerg Med; 2007 Nov; 14(11):965-7. PubMed ID: 17967957
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Kidney-related diseases and quality improvement: AHRQ's role.
    Clancy CM
    Clin J Am Soc Nephrol; 2011 Oct; 6(10):2531-3. PubMed ID: 21836151
    [No Abstract]   [Full Text] [Related]  

  • 32. Engraving marble and comparative effectiveness reviews.
    Braillon A
    J Clin Epidemiol; 2011 Dec; 64(12):1468-9. PubMed ID: 22032758
    [No Abstract]   [Full Text] [Related]  

  • 33. Science and the stiumulus. Medicine under the microscope.
    Marshall E
    Science; 2009 Nov; 326(5957):1183-5. PubMed ID: 19965447
    [No Abstract]   [Full Text] [Related]  

  • 34. AHRQ's Tools for Better Practice: Helping Family Physicians Manage Today's Challenges.
    Ganiats TG; Bierman AS
    Am Fam Physician; 2017 Nov; 96(9):569-570. PubMed ID: 29094872
    [No Abstract]   [Full Text] [Related]  

  • 35. The Capacity of Primary Care for Improving Evidence-Based Care: Early Findings From AHRQ's EvidenceNOW.
    Shoemaker SJ; McNellis RJ; DeWalt DA
    Ann Fam Med; 2018 Apr; 16(Suppl 1):S2-S4. PubMed ID: 29632218
    [No Abstract]   [Full Text] [Related]  

  • 36. Achieving provider support of pharmacy benefit design.
    Navarro RP
    Med Interface; 1995 Aug; 8(8):80-1, 84. PubMed ID: 10144776
    [No Abstract]   [Full Text] [Related]  

  • 37. An insider's perspective on the near-death experience of AHCPR.
    Gaus CR
    Health Aff (Millwood); 2003; Suppl Web Exclusives():W3-311-3. PubMed ID: 14527264
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Outcomes research, analysis, and dissemination: the federal government's role.
    Paduda J
    Med Interface; 1994 Feb; 7(2):52-4, 56-7. PubMed ID: 10132447
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Learning Collaboratives: Insights And A New Taxonomy From AHRQ's Two Decades Of Experience.
    Nix M; McNamara P; Genevro J; Vargas N; Mistry K; Fournier A; Shofer M; Lomotan E; Miller T; Ricciardi R; Bierman AS
    Health Aff (Millwood); 2018 Feb; 37(2):205-212. PubMed ID: 29401014
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Summary of AHRQ's comparative effectiveness review of angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers added to standard medical therapy for treating stable ischemic heart disease.
    White CM; Greene L
    J Manag Care Pharm; 2011 Jun; 17(5 Suppl):S1-15. PubMed ID: 21780334
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.